Rocuronium Bromide Injection, Solution
Product Images NDC 71839-141

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71839-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Rocuro100mgcarton)

The packaging label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) multiple-dose vials is shown. It includes warnings that it is a paralyzing agent for intravenous use only. The label mentions the product comes in 10 x 10 mL vials and is distributed by BE Pharmaceuticals Inc. Manufacturer details for Caplin Steriles Limited in India are provided, alongside storage and usage instructions.*

FDA Label Image

Vial (Rocuro100mgviallabel)

Label for Rocuronium Bromide Injection, 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label includes warnings about the drug being a paralyzing agent requiring facilities for artificial respiration. It indicates a 10 mL multiple-dose vial, sterile and nonpyrogenic. The product is manufactured by Caplin Steriles Limited, India, and distributed by BE Pharmaceuticals Inc., Cary, NC. Storage instructions specify refrigeration at 2° to 8°C with no freezing and usage timelines after removal from refrigeration and after opening.*

FDA Label Image

Carton (Rocuro50mgcarton)

Packaging label for Rocuronium Bromide Injection 10 mg/mL (50 mg/5 mL) multiple-dose vials. The label includes a warning for use as a paralyzing agent for intravenous use only. It indicates 10 vials of 5 mL each and states the product is sterile and nonpyrogenic. The labeler is BE Pharmaceuticals Inc., with manufacturing by Caplin Steriles Limited in India.*

FDA Label Image

Vial (Rocuro50mgviallabel)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL), an intravenous solution in a 5 mL multiple-dose vial. The label includes warnings that it is a paralyzing agent and requires immediate availability of artificial respiration. It is distributed by BE Pharmaceuticals Inc. and manufactured by Caplin Steriles Limited, India. Storage instructions specify refrigeration at 2° to 8°C and usage timelines after removal and opening.*

FDA Label Image

Figure1 (Rocurofigure1)

Scatter plot showing the relationship between dosage in mg/kg and response time in minutes for Rocuronium Bromide. The x-axis categorizes dosage and age groups: 18-64 years, 65 years and older, and 1-12 years. The y-axis measures response time in minutes. Data points are marked with stars and box plots highlight distribution within groups.*

FDA Label Image

Figure2 (Rocurofigure2)

A box-and-whisker plot displaying the duration in minutes of Rocuronium Bromide 10 mg/mL injection at various dosage levels across different age groups, ranging from 3 months to 64 years and older. The horizontal axis categorizes age and dosage in mg/kg, while the vertical axis measures time in minutes, illustrating variability in drug effect duration among subjects.*

FDA Label Image

Figure3 (Rocurofigure3)

A line chart displaying the relationship between Dose Number (x-axis) and Minutes (y-axis) for rocuronium bromide at doses of 0.1 mg/kg and 0.15 mg/kg. Two lines represent these dose levels, with data points labeled for sample sizes N=29 and N=13, respectively.*

FDA Label Image

Structure (Rocurostrucaplin)

Chemical structure diagram of rocuronium bromide, showing the molecular arrangement and bonding of the active ingredient in Rocuronium Bromide injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.